169 related articles for article (PubMed ID: 27716646)
1. Modelling topical photodynamic therapy treatment including the continuous production of Protoporphyrin IX.
Campbell CL; Brown CT; Wood K; Moseley H
Phys Med Biol; 2016 Nov; 61(21):7507-7521. PubMed ID: 27716646
[TBL] [Abstract][Full Text] [Related]
2. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo modelling of daylight activated photodynamic therapy.
Campbell CL; Wood K; Valentine RM; Brown CT; Moseley H
Phys Med Biol; 2015 May; 60(10):4059-73. PubMed ID: 25927971
[TBL] [Abstract][Full Text] [Related]
4. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
5. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison.
LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW
Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
Bay C; Lerche CM; Ferrick B; Philipsen PA; Togsverd-Bo K; Haedersdal M
JAMA Dermatol; 2017 Apr; 153(4):270-278. PubMed ID: 28146245
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
[TBL] [Abstract][Full Text] [Related]
8. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
[TBL] [Abstract][Full Text] [Related]
10. The background and philosophy behind daylight photodynamic therapy.
Wulf HC
G Ital Dermatol Venereol; 2018 Dec; 153(6):776-782. PubMed ID: 29683283
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M
Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358
[TBL] [Abstract][Full Text] [Related]
12. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Wiegell SR; Fabricius S; Heydenreich J; Enk CD; Rosso S; Bäumler W; Baldursson BT; Wulf HC
Br J Dermatol; 2013 Jan; 168(1):186-91. PubMed ID: 22860885
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas.
Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K
J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry model for photodynamic therapy with topically administered photosensitizers.
Svaasand LO; Wyss P; Wyss MT; Tadir Y; Tromberg BJ; Berns MW
Lasers Surg Med; 1996; 18(2):139-49. PubMed ID: 8833282
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
[TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities.
Nadeau V; O'Dwyer M; Hamdan K; Tait I; Padgett M
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):170-4. PubMed ID: 15238094
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
Osman-Ponchet H; Sevin K; Gaborit A; Kouidhi M; Hanaizi J; Comby P; Ruty B; Bouvier G
Photodiagnosis Photodyn Ther; 2017 Mar; 17():75-81. PubMed ID: 27903435
[TBL] [Abstract][Full Text] [Related]
19. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.
Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS
Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
